ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 610

Ankylosing Spondylitis-associated Killer Immunoglobin-like Receptors Are Strongly Expressed on γδ T Cells

Micah Lefton1, Nihaarika Sharma 1 and Joerg Ermann 2, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: ankylosing spondylitis (AS) and human, KIR (Killer Ig like receptor), lymphocytes

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The mechanism underlying the association between ankylosing spondylitis (AS) and HLA-B27 is still unknown. One of the hypotheses involves the interaction of HLA-B27 homodimers with KIR3DL2 receptors on CD4+ T cells. KIR3DL2 is a member of the killer immunoglobin-like receptor (KIR) family of MHC class I ligands that transmit activating or inhibitory signals to KIR expressing lymphocytes. KIR3DL2 binds to HLA-B27 homodimers whereas KIR3DL1 interacts with native HLA-B27 complexes. Previous work has shown an expansion of KIR3DL2 positive IL-17A producing CD4+ T cells in HLA-B27 positive patients with AS.  Multiple other IL-17A producing lymphocyte subsets including γδ T cells have been implicated in AS pathogenesis. The purpose of this study was to further characterize the expression of KIR3DL2 and KIR3DL1 on these lymphocyte subsets.

Methods: Human peripheral blood mononuclear cells (PBMC) were prepared by Ficoll density gradient centrifugation from the blood of healthy individuals. To measure cytokine production, PBMC were stimulated with PMA/ionomycin for 4 hours in the presence of brefeldin A/monensin followed by intracellular staining. In other experiments, PBMC were stimulated with phytohemagglutinin (PHA) for up to 3 days in medium supplemented with IL-2 and IL-7. Cells were analyzed using a 19-parameter flow cytometry panel that distinguishes natural killer (NK) cells, mucosal-associated invariant T (MAIT) cells, CD4+ T cells, CD8+ T cells, CD4-CD8- DN αβ T cells and γδ T cells further subdivided into Vδ1+, Vδ2+ and other γδ T cells. MAIT cells were identified using MR1 tetramers. Lineage markers were combined with antibodies specific for relevant KIRs and cytokines. Flow cytometric analysis was performed using a 5-laser BD LSRFortessa cytometer and FlowJo software.

Results: KIR3DL2 and KIR3DL1 were variably expressed by all lymphocyte subsets analyzed. The highest frequencies of KIR expressing cells were observed for NK and γδ T cells, in particular Vδ1 cells. Only a small fraction of CD4+ T cells stained positive for KIR3DL2 in our cohort of healthy individuals. The highest frequency of IL-17A secreting cells was observed amongst MAIT and CD4+ T cells. When stratified based on KIR3DL2 expression, IL-17A expression was enriched in KIR3DL2+ cells in most subsets, regardless of whether the blood was from HLA-B27+ or HLA-B27- subjects. γδ and other T cells but not NK cells upregulated KIR3DL2 and KIR3DL1 upon stimulation with PHA in vitro.

Conclusion: AS-associated KIRs (KIR3DL2, KIR3DL1) are strongly expressed on γδ T cells in healthy individuals and further upregulated upon stimulation. Our data suggest that studies testing the KIR hypothesis for the HLA-B27 association of AS should consider a wider spectrum of KIR expressing lymphocytes including γδ T cells.


Lefton_Fig1

KIR3DL2 Expression on Lymphocyte Subsets in Peripheral Blood of Healthy Individuals


Disclosure: M. Lefton, None; N. Sharma, None; J. Ermann, Boehringer Ingelheim, 2, Eli Lilly, 5, Novartis, 5, Pfizer, 2, UCB, 5.

To cite this abstract in AMA style:

Lefton M, Sharma N, Ermann J. Ankylosing Spondylitis-associated Killer Immunoglobin-like Receptors Are Strongly Expressed on γδ T Cells [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/ankylosing-spondylitis-associated-killer-immunoglobin-like-receptors-are-strongly-expressed-on-%ce%b3%ce%b4-t-cells/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ankylosing-spondylitis-associated-killer-immunoglobin-like-receptors-are-strongly-expressed-on-%ce%b3%ce%b4-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology